US 8969356
Compounds useful as inhibitors of ATR kinase
granted A61PA61P35/00A61P43/00
Quick answer
US patent 8969356 (Compounds useful as inhibitors of ATR kinase) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61P, A61P35/00, A61P43/00